PFE.XETRA Pfizer Inc

Healthcare Pharmaceuticals XETRA Stock Exchange
27.33 EUR
Close of Nov 5, 2026
19.44 27.63
Market cap
EUR 156B
P/E
45.6x
P/B
1.95x
ROE
8.7%
Dividend yield
5.65%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PFE.XETRA undervalued?

Graham number
Price27.33
Graham value13.75
Premium98.7%

PFE.XETRA trades 98.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pfizer Inc fundamental analysis

No fundamental analysis for Pfizer Inc yet.

Pfizer Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, …

Full company profile